Parenteral Nutrition Market will Approximated to be USD 14.3 Billion in Advance of 2035; Market is enlarged due to Advancements in Formulation and Safety

Download Sample

Published Date: May 2025

Parenteral nutrition market is a method of delivering nutrients directly into a patient’s bloodstream through a catheter inserted into a vein, bypassing the digestive system. This method is used in patient which are unable to eat or absorb nutrients through their gut due to illness or injury. Innovations in nutrient composition, packaging, and delivery systems have improved the safety, stability, and efficacy of PN products, increasing their adoption across hospitals and home care, is expected to pitch parenteral nutrition market growth.

Segmentation Analysis:

By Product	Amino Acid Solution, Dextrose Injections, Sterile Water, Fat Emulations, and Potassium Chloride
By Consumer Type	New-Born & Children, and Adults
By Indication	Alzheimer’s, Nutrition Deficiency, Chronic Kidney Diseases, Cancer Care, Orphan Diseases, Diabetes, Pain Management, and Others
By Distribution Channel	Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Report Highlights:

Parenteral nutrition market size is accounted for USD 7.9 Billion in 2025.
The target market size is anticipated to expand at a rate of USD 14.3 Billion by 2035, and increasing at a CAGR of 6.7%.
Based on product, amino acid segment has largest parenteral nutrition market share.
On the basis of consumer type, adults hold the major parenteral nutrition market share.
The cancer care is leading segment in parenteral nutrition market size, by application.
Under end-user, hospital pharmacies is the most dominating segment in parenteral nutrition market share.
North America holds the largest parenteral nutrition market share.
Asia Pacific is second leading region in the target market growth.

Market Dynamics:

Growing Factor	Challenge Factor	Market Trend
Growing Geriatric Population	Limited Awareness and Availability in Developing Countries	Integration of AI and Monitoring in PN Administration

Key Highlights

In October 2024, Fresenius Kabi launched Kanbiven for intravenous use. Kabiven is a parenteral nutrition (PN) product in a three-chamber bag which was approved in the U.S. It was an intravenously infused solution of lipids, dextrose, amino acids and electrolytes in a three-chamber bag that efficiently delivered these nutrients in volumes and concentrations that required for the nutritional needs in patients.

Report Analysis:

Venous Access for Parenteral Nutrition:

Venous access is a critical component in the administration of parenteral nutrition (PN), which delivers essential nutrients, such as carbohydrates, proteins, fats, vitamins, and minerals directly into the bloodstream, bypassing the gastrointestinal tract. The selection of the appropriate venous access route depends on factors such as duration of therapy, type of nutrition, patient condition, and care setting.

Types of Venous Access:

Peripheral Venous Access: Peripheral venous access involves inserting a short catheter into a small vein, usually in the arm or hand. This method is primarily used for Peripheral Parenteral Nutrition (PPN), which is suitable for short-term nutritional support, typically less than two weeks.
Central Venous Access: Central venous access delivers nutrition into a large central vein, such as the superior vena cava, allowing the use of hypertonic and nutrient-dense solutions. This method is essential for Total Parenteral Nutrition (TPN), especially when high volumes or long-term support are needed.

Browse ∼60 market data tables and ∼35 figures through ∼160 slides and in-depth TOC on “Parenteral Nutrition Market, Size, Share, By Product (Amino Acid Solution, Dextrose Injections, Sterile Water, Fat Emulations, and Potassium Chloride), Consumer Type (New-Born & Children, and Adults), Indication (Alzheimer’s, Nutrition Deficiency, Chronic Kidney Diseases, Cancer Care, Orphan Diseases, Diabetes, Pain Management, and Others), Distributional Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region - Trends, Analysis, and Forecast till 2035”

Segmentation:

By Product:

Amino Acid Solution
Dextrose Injections
Sterile Water
Fat Emulations
Potassium Chloride
Others

By Consumer Type:

New-Born & Children
Adults

By Indication:

Alzheimer’s
Nutrition Deficiency
Chronic Kidney Diseases
Cancer Care
Orphan Diseases
Diabetes
Pain Management
Others

By Distributional Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Research Laboratories

By Region:

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa

For more insights into the Parenteral Nutrition Market and its future trends, visit link below: https://www.prophecymarketinsights.com/market_insight/Global-Parenteral-Nutrition-Market-By-1291

Competitive Landscape of Parenteral Nutrition Market:

The key players operating the parenteral nutrition market include Fresenius Kabi India Pvt. Ltd., Baxter, Amanta Healthcare, AbbVie Inc., Aculife, B. Braun SE, ICU Medical, Inc., Grifols, S.A., Option Care Health Inc., CSL, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Abbott, Sanofi, Otsuka Pharmaceutical India Pvt. Ltd., Pfizer Inc.